172 related articles for article (PubMed ID: 7354081)
1. Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils.
Macher BA; Klock JC
J Biol Chem; 1980 Mar; 255(5):2092-6. PubMed ID: 7354081
[TBL] [Abstract][Full Text] [Related]
2. Isolation and structural characterization of human lymphocyte and neutrophil gangliosides.
Macher BA; Klock JC; Fukuda MN; Fukuda M
J Biol Chem; 1981 Feb; 256(4):1968-74. PubMed ID: 6780555
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.
Teneberg S; Lönnroth I; Torres López JF; Galili U; Halvarsson MO; Angström J; Karlsson KA
Glycobiology; 1996 Sep; 6(6):599-609. PubMed ID: 8922955
[TBL] [Abstract][Full Text] [Related]
4. Neutral glycosphingolipids in hairy cell leukemia.
Lee WM; Klock JC; Macher BA
Biochemistry; 1981 Oct; 20(22):6505-8. PubMed ID: 7306520
[TBL] [Abstract][Full Text] [Related]
5. Studies on the chemical structure of neutral glycosphingolipids in eggs of the sea hare, Aplysia juliana.
Yamaguchi Y; Konda K; Hayashi A
Biochim Biophys Acta; 1992 Nov; 1165(1):110-8. PubMed ID: 1420340
[TBL] [Abstract][Full Text] [Related]
6. Beta 1-3-N-acetylglucosaminyltransferase in human leukocytes: properties and role in regulating neolacto glycosphingolipid biosynthesis.
Stults CL; Macher BA
Arch Biochem Biophys; 1993 May; 303(1):125-33. PubMed ID: 8489255
[TBL] [Abstract][Full Text] [Related]
7. Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13.
Galili U; Basbaum CB; Shohet SB; Buehler J; Macher BA
J Biol Chem; 1987 Apr; 262(10):4683-8. PubMed ID: 2435715
[TBL] [Abstract][Full Text] [Related]
8. Changes in glycosphingolipids accompanying the differentiation of human squamous SQCC/Y1 cells.
Tatsumura T; Ariga T; Yu RK; Sartorelli AC
Cancer Res; 1988 Apr; 48(8):2121-4. PubMed ID: 3258184
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of glycosphingolipids from human leukocytes. A unique glycosphingolipid pattern in a case of acute myelomonoblastic leukemia.
Lee WM; Westrick MA; Klock JC; Macher BA
Biochim Biophys Acta; 1982 Apr; 711(1):166-75. PubMed ID: 6950793
[TBL] [Abstract][Full Text] [Related]
10. [A novel blood group A- and O (H) -antigens--glycosphingolipids from porcine erythrocytes].
Sako F
Hokkaido Igaku Zasshi; 1988 Jul; 63(4):534-44. PubMed ID: 3220436
[TBL] [Abstract][Full Text] [Related]
11. Fucosylated glycosphingolipids of human myeloid cells.
Kong RK; Barrios A; Knapp W; Macher BA
Arch Biochem Biophys; 1993 Feb; 300(2):677-83. PubMed ID: 8434948
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of intermediates in the biosynthetic pathway of neolacto glycosphingolipids: differential expression in human leukaemia cells.
Hu J; Stults CL; Holmes EH; Macher BA
Glycobiology; 1994 Jun; 4(3):251-7. PubMed ID: 7949652
[TBL] [Abstract][Full Text] [Related]
13. The mono- and difucosyl blood group B glycosphingolipids of rat large intestine differ in type of core saccharide.
Angström J; Falk P; Hansson GC; Holgersson J; Karlsson H; Karlsson KA; Strömberg N; Thurin J
Biochim Biophys Acta; 1987 Oct; 926(1):79-86. PubMed ID: 3651504
[TBL] [Abstract][Full Text] [Related]
14. Chemical characterization of a blood group H type pentaglycosylceramide of human small intestine.
Breimer ME; Karlsson KA; Larson G; McKibbin JM
Chem Phys Lipids; 1983 Aug; 33(2):135-44. PubMed ID: 6578878
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a major neutral glycolipid in PC12 cells as III3Gal alpha-globotriaosylceramide by the method for determining glycosphingolipid saccharide sequence with endoglycoceramidase.
Shimamura M; Hayase T; Ito M; Rasilo ML; Yamagata T
J Biol Chem; 1988 Aug; 263(24):12124-8. PubMed ID: 3403562
[TBL] [Abstract][Full Text] [Related]
16. Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicity.
Taki T; Ogura K; Rokukawa C; Hara T; Kawakita M; Endo T; Kobata A; Handa S
Cancer Res; 1991 Mar; 51(6):1701-7. PubMed ID: 1998961
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcus neoformans, Candida albicans, and other fungi bind specifically to the glycosphingolipid lactosylceramide (Gal beta 1-4Glc beta 1-1Cer), a possible adhesion receptor for yeasts.
Jimenez-Lucho V; Ginsburg V; Krivan HC
Infect Immun; 1990 Jul; 58(7):2085-90. PubMed ID: 2194958
[TBL] [Abstract][Full Text] [Related]
18. Isolation and structural characterization of human lymphocyte neutral glycosphingolipids.
Lee WM; Klock JC; Macher BA
Biochemistry; 1981 Jun; 20(13):3810-4. PubMed ID: 7272278
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the expression of Gal alpha 1-3Gal beta 1-4GlcNAc glycosphingolipids in kidney.
Hendricks SP; He P; Stults CL; Macher BA
J Biol Chem; 1990 Oct; 265(29):17621-6. PubMed ID: 2211651
[TBL] [Abstract][Full Text] [Related]
20. Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin.
Stroud MR; Handa K; Salyan ME; Ito K; Levery SB; Hakomori S; Reinhold BB; Reinhold VN
Biochemistry; 1996 Jan; 35(3):770-8. PubMed ID: 8547257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]